Confluence Pharmaceuticals LLC — Form D
Confluence Pharmaceuticals LLC of CARMEL, IN, a company, filed a Form D exempt-offering notice with the SEC on 2018-10-04. The offering totals $800K, of which $10K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-10-04
- Form: D
- Accession: 0001689048-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $10K
- Remaining: $790K
- Minimum investment: $10K
- Investors: 1
- Date of first sale: 2018-09-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-322791
Issuer
- Name: Confluence Pharmaceuticals LLC
- CIK: 0001689048
- Entity type: Limited Liability Company
- Jurisdiction: INDIANA
- Address: 4904 DEER RIDGE DRIVE SOUTH, CARMEL, IN, 46033
- Phone: (317) 379-7498
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Steven L Johns | Director | Carmel, IN |
| Phil W Lodato | Director | Indianapolis, IN |
| Boyd W Sturdevant, Jr. | Director | Unionville, IN |
| Steven L Johns | Executive Officer | Carmel, IN |
Other filings by this issuer (1)
More